IL122576A0 - Sulfonamide-substituted compounds processes for their preparation their use as medicament or diagnostic and pharmaceutical preparation comprising them - Google Patents

Sulfonamide-substituted compounds processes for their preparation their use as medicament or diagnostic and pharmaceutical preparation comprising them

Info

Publication number
IL122576A0
IL122576A0 IL12257697A IL12257697A IL122576A0 IL 122576 A0 IL122576 A0 IL 122576A0 IL 12257697 A IL12257697 A IL 12257697A IL 12257697 A IL12257697 A IL 12257697A IL 122576 A0 IL122576 A0 IL 122576A0
Authority
IL
Israel
Prior art keywords
nme2
ome
nhso2me
so2me
so2nh2
Prior art date
Application number
IL12257697A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1996152213 external-priority patent/DE19652213A1/de
Priority claimed from DE1997130326 external-priority patent/DE19730326A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL122576A0 publication Critical patent/IL122576A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/161,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with only hydrogen or carbon atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
IL12257697A 1996-12-16 1997-12-12 Sulfonamide-substituted compounds processes for their preparation their use as medicament or diagnostic and pharmaceutical preparation comprising them IL122576A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1996152213 DE19652213A1 (de) 1996-12-16 1996-12-16 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1997130326 DE19730326A1 (de) 1997-07-15 1997-07-15 Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen

Publications (1)

Publication Number Publication Date
IL122576A0 true IL122576A0 (en) 1998-06-15

Family

ID=26032247

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12257697A IL122576A0 (en) 1996-12-16 1997-12-12 Sulfonamide-substituted compounds processes for their preparation their use as medicament or diagnostic and pharmaceutical preparation comprising them

Country Status (24)

Country Link
US (1) US5856338A (hu)
EP (1) EP0847996B1 (hu)
JP (1) JP4317601B2 (hu)
KR (1) KR19980064151A (hu)
CN (1) CN1185435A (hu)
AT (1) ATE234821T1 (hu)
AU (1) AU725699B2 (hu)
BR (1) BR9706142A (hu)
CA (1) CA2224885A1 (hu)
CZ (1) CZ403997A3 (hu)
DE (1) DE59709560D1 (hu)
DK (1) DK0847996T3 (hu)
ES (1) ES2195071T3 (hu)
HR (1) HRP970684A2 (hu)
HU (1) HUP9702475A3 (hu)
ID (1) ID19152A (hu)
IL (1) IL122576A0 (hu)
NO (1) NO975887L (hu)
NZ (1) NZ329200A (hu)
PL (1) PL323809A1 (hu)
PT (1) PT847996E (hu)
SI (1) SI0847996T1 (hu)
SK (1) SK171797A3 (hu)
TR (1) TR199701605A2 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711220D0 (en) * 1997-05-30 1997-07-23 Isis Innovation Antiarrhythmic agents
EP1276893A4 (en) 2000-04-14 2005-05-04 Univ Vanderbilt NUCLEIC ACIDS AND PYRIFICATED POYPEPTIDES AND ISOLES COTRANSPORTORS OF POTASSIUM CHLORIDE
TWI349666B (en) * 2004-03-12 2011-10-01 Lundbeck & Co As H Substituted morpholine and thiomorpholine derivatives
CN113402476B (zh) * 2021-06-21 2022-04-19 广东湛江海洋医药研究院 一种亚胺噁嗪衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
GB8808069D0 (en) * 1988-04-07 1988-05-11 Fujisawa Pharmaceutical Co Benzopyran derivatives & processes for preparation thereof
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof
TW258735B (hu) * 1992-08-17 1995-10-01 Chugai Pharmaceutical Co Ltd
CN1204134C (zh) * 1996-05-15 2005-06-01 赫彻斯特股份公司 氨磺酰-取代的苯并二氢吡喃,其制法,作为药物或诊断剂的应用及含有它的药物

Also Published As

Publication number Publication date
NZ329200A (en) 1999-05-28
JPH10182610A (ja) 1998-07-07
EP0847996B1 (de) 2003-03-19
JP4317601B2 (ja) 2009-08-19
PT847996E (pt) 2003-07-31
NO975887D0 (no) 1997-12-15
PL323809A1 (en) 1998-06-22
TR199701605A2 (xx) 1998-07-21
CN1185435A (zh) 1998-06-24
CA2224885A1 (en) 1998-06-16
DK0847996T3 (da) 2003-06-30
ATE234821T1 (de) 2003-04-15
NO975887L (no) 1998-06-17
HUP9702475A2 (hu) 1999-06-28
KR19980064151A (ko) 1998-10-07
US5856338A (en) 1999-01-05
AU725699B2 (en) 2000-10-19
SI0847996T1 (en) 2003-08-31
CZ403997A3 (cs) 1998-07-15
ES2195071T3 (es) 2003-12-01
BR9706142A (pt) 1999-05-18
DE59709560D1 (de) 2003-04-24
HU9702475D0 (en) 1998-03-02
SK171797A3 (en) 1998-07-08
HUP9702475A3 (en) 2000-01-28
EP0847996A1 (de) 1998-06-17
MX9710126A (es) 1998-07-31
AU4837397A (en) 1998-06-18
ID19152A (id) 1998-06-18
HRP970684A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
HUP0300922A2 (hu) Új vegyületek, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE69530683D1 (de) Sulfonamid derivate und deren verwendung
HUP0300413A2 (hu) Amidcsoportot viselő benzolgyűrűs csoporttal helyettesített piperidint tartalmazó és rokonszerkezetű vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
NO863980D0 (no) Fremgangsmaate for fremstilling av kinazolinderivater.
FI831604A0 (fi) Pyridinderivat, deras framstaellning och anvaendning
ES2192394T3 (es) Profarmacos de inhibidores de la bomba de protones.
HUP9802534A2 (hu) Neurotranszmitter újrafelvételt gátló kondenzált tropánszármazékok és előállításuk, e vegyületeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
HUP0402640A2 (hu) Indolilalkilamin-származékok 5-hidroxitriptamin-6 ligandumokként, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
DE69901006D1 (de) Benzothiophen-, Benzofuran- und Indolderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
HRP20070194T3 (en) N-thiazol-2-yl-benzamide derivatives
DE69003200D1 (de) Arylsubstituierte Aminderivate verwendbar in der Krebstherapie.
DZ1694A1 (fr) "n-(2-Aminoethyl)-benzothialozones".
IE892189L (en) Derivatives of (aza) naphthalenesultam, their preparation¹and compositions containing them
IL122576A0 (en) Sulfonamide-substituted compounds processes for their preparation their use as medicament or diagnostic and pharmaceutical preparation comprising them
DK0599240T3 (da) Indol-7-carboxamidderivater som analgetika
DK283984A (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
NZ335055A (en) Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents and process for its production
EA200400666A3 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
TH1033EX (th) การใช้ไนโตร อะมิโน และเอโรอิลอะมิโน-n- เฟนนิลพิริดีนอะมีนในกรรมวิธีการเตรียมสารพิริโด [1,4] -เบนโซไดอะซิฟินซึพีนต่าง ๆ
TH17530EX (th) อนุพันธ์ของไทรแอซีน, การผลิตและการใช้สารเหล่านั้น